Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • cytokine storm

Tag: cytokine storm

  • BiotechToday
  • World

DO COVID-19 PATIENTS BENEFIT FROM TOCILIZUMAB AT ALL?

bioxone October 25, 2020October 25, 2020

Arpan Banerjee, University of Calcutta Since the time Covid-19 has plagued the entire world, many studies have evolved emphasizing its heterogeneous clinical presentation, ranging from silent asymptomatic carriers to the severe ones bogged down with respiratory failure. The clinical trials about the finding of the wonder drug is still awaited. In the meantime, several drugs […]

Read More
  • BiotechToday
  • World

Intravenous Tocilizumab Therapy can tackle Cytokine Storm in COVID-19 patients

bioxone October 24, 2020October 24, 2020

Chitra Roy, University of Calcutta Since its emergence, COVID-19 has been constantly challenging the medical health system across the globe. COVID-19 infection is primarily accompanied by the aggressive inflammatory response with the release of excessive amounts of pro-inflammatory cytokines which are called ‘Cytokine Storm’. The immune response of the host to SARS-CoV-2 virus is extremely […]

Read More
  • BiotechToday
  • World

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

bioxone October 20, 2020October 20, 2020

Sampriti Roy, Asutosh College, University of Calcutta SARS-CoV-2, the talk of the town (read “world”), still lacks information related to its origin and exact mechanism.  The virus, found to cause DAD (diffuse alveolar damage), leads to respiratory failure which appears to be the common mechanism of death in patients with severe COVID-19 infection. However, with […]

Read More
  • BiotechToday
  • World

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020 1

Anwesha Chatterjee, Amity University Kolkata The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection […]

Read More
  • BiotechToday
  • World

Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

bioxone October 18, 2020October 18, 2020

Sayak Banerjee, Amity University Kolkata Down syndrome (DS), also known as trisomy 21 is the most persistent aneuploidy characterized by a genetic disorder caused due to the triplication of the 21st human chromosome. This syndrome is particularly associated with the development of congenital heart disease, sleep apnoea, obesity, diabetes, premature ageing, and higher sensitivity to […]

Read More
  • BiotechToday
  • World

COVID update: One out of seven critical COVID cases may result from faulty immune responses

bioxone October 3, 2020October 3, 2020 1

SAGNIK  NAG, AMITY UNIVERSITY KOLKATA Our immune system plays an imperative role in combating the uncertainties of COVID-19. The most concerning fact regarding the ailment is its alarming range of severity – from being asymptotic to completely fatal. Standing today we know all the precautions that are to be followed during this pandemic situation, we […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy